[C:1](=O)([O:37]C1C=CC([N+]([O-])=O)=CC=1)[O:2][C@H:3]([CH2:18][C:19]1[CH:27]=[C:26]([CH3:28])[C:25]2[C:21](=[CH:22][N:23]([CH2:29][O:30][CH2:31][CH2:32][Si:33]([CH3:36])([CH3:35])[CH3:34])[N:24]=2)[CH:20]=1)[C:4](=[O:17])[N:5]1[CH2:10][CH2:9][CH:8]([N:11]2[CH2:16][CH2:15][CH2:14][CH2:13][CH2:12]2)[CH2:7][CH2:6]1.[F:48][C:49]1[CH:58]=[C:57]2[C:52]([CH2:53][N:54]([CH:60]3[CH2:65][CH2:64][NH:63][CH2:62][CH2:61]3)[C:55](=[O:59])[NH:56]2)=[CH:51][CH:50]=1.C(N(C(C)C)CC)(C)C>CN(C)C=O>[F:48][C:49]1[CH:58]=[C:57]2[C:52]([CH2:53][N:54]([CH:60]3[CH2:65][CH2:64][N:63]([C:1]([O:2][C@H:3]([CH2:18][C:19]4[CH:27]=[C:26]([CH3:28])[C:25]5[C:21](=[CH:22][N:23]([CH2:29][O:30][CH2:31][CH2:32][Si:33]([CH3:35])([CH3:34])[CH3:36])[N:24]=5)[CH:20]=4)[C:4](=[O:17])[N:5]4[CH2:10][CH2:9][CH:8]([N:11]5[CH2:16][CH2:15][CH2:14][CH2:13][CH2:12]5)[CH2:7][CH2:6]4)=[O:37])[CH2:62][CH2:61]3)[C:55](=[O:59])[NH:56]2)=[CH:51][CH:50]=1To a solution of (R)-3-(7-methyl-2-((2-(trimethylsilyl)ethoxy)methyl)-2H-indazol-5-yl)-1-oxo-1-(4-(piperidin-1-yl)piperidin-1-yl)propan-2-yl 4-nitrophenyl carbonate (150 mg, 0.23 mmol) and 7-fluoro-3-(piperidin-4-yl)-3,4-dihydroquinazolin-2(1H)-one (56.2 mg, 1.0 equiv) in dimethylformamide (1 mL) was added diisopropylethylamine (79 μL, 0.45 mmol) and the reaction stirred at room temperature overnight. The reaction was concentrated and purified by column chromatography (3:97:1 methanol/dichloromethane/triethylamine) to give 93 mg (53%) as a tan foam solid. Mass spec.: 776.48 (MH)+.